Pell Bio-Med Technology Co., Ltd. (TPE:6949)

Pell Bio-Med Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,852	306.7	427.37	167.68	172.4	115.78
Short-Term Investments	416.31	351	479.75	938.15	536	-
Trading Asset Securities	-	-	29.06	-	-	-
Cash & Short-Term Investments	2,269	657.7	936.18	1,106	708.4	115.78
Cash Growth	197.94%	-29.75%	-15.34%	56.10%	511.84%	-
Accounts Receivable	7.73	5.07	3.75	7.61	6.05	4.5
Other Receivables	4.17	3.21	2.4	0.33	0.36	6.12
Receivables	11.91	8.27	6.15	7.94	6.41	10.62
Inventory	19.21	6.62	6.18	3.76	4.58	4.24
Prepaid Expenses	38.44	5.46	9.22	8.86	5.84	1.1
Other Current Assets	0.38	653.37	200	0.65	0.16	0.08
Total Current Assets	2,339	1,331	1,158	1,127	725.39	131.82
Property, Plant & Equipment	723.34	709.81	386.45	260.92	298.97	249.74
Long-Term Investments	0.27	0.27	0.37	0.37	0.26	0.26
Other Intangible Assets	20.24	2.93	1.89	2.4	2.71	1.47
Other Long-Term Assets	73.02	67.8	198.39	27.44	17.07	10.61
Total Assets	3,156	2,112	1,745	1,418	1,044	393.89

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.33	5.83	4.49	6.99	5.72	8.61
Accrued Expenses	-	106.49	64.12	39.74	14.58	19.19
Short-Term Debt	100	100	200	-	5	-
Current Portion of Leases	30.13	27.99	27.55	25.09	25.07	10.76
Current Unearned Revenue	-	0.02	0.02	-	-	0.75
Other Current Liabilities	93.73	68.64	25.17	17.47	6.86	4.87
Total Current Liabilities	232.19	308.97	321.35	89.3	57.24	44.18
Long-Term Leases	-	109.28	137.27	147.47	172.56	124.84
Other Long-Term Liabilities	0.02	0.02	-	-	-	-
Total Liabilities	333.59	418.27	458.62	236.77	229.79	169.02

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	655.8	587.98	578.43	539.43	443.65	333.76
Additional Paid-In Capital	3,713	1,910	1,804	1,449	774.25	77.38
Retained Earnings	-1,796	-1,631	-1,207	-817.85	-419.09	-188.96
Treasury Stock	-0.6	-0.8	-0.8	-0.8	-	-
Comprehensive Income & Other	-	555.74	5.52	-	2.13	2.69
Total Common Equity	2,572	1,422	1,180	1,170	800.94	224.86
Minority Interest	249.94	272.07	106.29	11.18	13.67	0.01
Shareholders' Equity	2,822	1,694	1,286	1,181	814.6	224.87
Total Liabilities & Equity	3,156	2,112	1,745	1,418	1,044	393.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	130.13	237.27	364.82	172.56	202.63	135.6
Net Cash (Debt)	2,139	420.43	571.36	933.27	505.77	-19.82
Net Cash Growth	421.13%	-26.41%	-38.78%	84.52%	-	-
Net Cash Per Share	34.49	7.17	10.01	20.17	12.89	-0.60
Filing Date Shares Outstanding	65.37	58.72	57.8	53.9	44.36	33.28
Total Common Shares Outstanding	65.37	58.72	57.8	53.9	44.36	33.28
Working Capital	2,107	1,022	836.38	1,038	668.15	87.64
Book Value Per Share	39.35	24.22	20.41	21.71	18.05	6.76
Tangible Book Value	2,552	1,419	1,178	1,168	798.22	223.39
Tangible Book Value Per Share	39.04	24.17	20.38	21.67	17.99	6.71
Machinery	-	310.33	95.05	90.37	81.84	75.31
Construction In Progress	-	285.99	148.34	-	-	-
Leasehold Improvements	-	104.12	86.72	86.72	86.18	86

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error